AzTrials
AzTrials

Post-Traumatic Stress DisorderPhase 1/2NCT02687555

The Role of Computerized Training in Post-Traumatic Stress Disorder

A Phase 1/2 study testing Cognitive Bias Modification of Appraisals (CBM-App) in people with Post-Traumatic Stress Disorder, run by Ruhr University of Bochum at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether a computerized training, "Cognitive Bias Modification" targetting appraisals (CBM-App), can reduce dysfunctional appraisals of trauma in patients with Post-Traumatic Stress Disorder (PTSD), compared to a control condition. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Post-Traumatic Stress Disorder
What is being tested?
Cognitive Bias Modification of Appraisals (CBM-App)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
1 siteGermany
Study dates
Feb 2016to May 2019
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Primary diagnosis of Post-Traumatic Stress Disorder according to ICD-10 (F43.1), and DSM-5 (as assessed via Clinician Adminstered PTSD Scale for DSM-5)
  • motivated and willing to take part in the study (including questionnaire measures, computer training, filling out questionnaires after discharge)
  • aged 18-60 years, male or female
  • fluent in German

Who cannot join

  • Substance abuse/ substance dependence currently or in the past six months
  • active suicidal thoughts or intentions
  • psychotic disorder (past or present)
  • learning disability/ intellectual impairment
  • red-green colour blindness

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Clinic for Psychosomatic Medicine and Psychotherapy, LWL University Clinic of Ruhr University of Bochum

    Bochum, North Rhine-Westphalia, 44791

Other trials in Germany

About this study

The purpose of this study is to determine whether a computerized training, "Cognitive Bias Modification" targetting appraisals (CBM-App), can reduce dysfunctional appraisals of trauma in patients with Post-Traumatic Stress Disorder (PTSD), compared to a control condition. Other outcomes measured include symptoms of PTSD and trauma-relevant dysfunctional cognitions. Participants are recruited from inpatients with PTSD admitted to the Clinic for Psychosomatic Medicine and Psychotherapy, LWL University Clinic of Ruhr University of Bochum.

Being tested
Cognitive Bias Modification of Appraisals (CBM-App), Peripheral Vision Task (control condition)
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Bias Modification of Appraisals (CBM-App)Behavioural

  • Peripheral Vision Task (control condition)Behavioural

Study groups in NCT02687555
Study groupRoleWhat they receive
InterventionExperimentalComputerized Cognitive Bias Modification of Appraisals (CBM-App), developed from that used by Woud et al. (2012,2013). The intervention comprises 8 sessions completed over a period of 2 weeks. The training takes place while participants are also receiving specialized inpatient treatment for PTSD at the Clinic for Psychosomatic Medicine and Psychotherapy, LWL University Clinic of Ruhr University of Bochum.
Receives: Behavioral: Cognitive Bias Modification of Appraisals (CBM-App)
ControlSham comparatorComputerized Peripheral Vision Task (PVT), developed from that used by Calkins et al. (2015). The intervention comprises 8 sessions completed over a period of 2 weeks. The training takes place while participants are also receiving specialized inpatient treatment for PTSD at the Clinic for Psychosomatic Medicine and Psychotherapy, LWL University Clinic of Ruhr University of Bochum.
Receives: Behavioral: Peripheral Vision Task (control condition)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dysfunctional trauma-related appraisals as measured using an open-ended ambiguous scenarios task

    Measured: Post-intervention (~ 2 weeks post-baseline)

Secondary outcomes (5)
  1. Dysfunctional trauma-related appraisals as measured using an open-ended ambiguous scenarios task

    Measured: Baseline, Mid-intervention (~1 week post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-discharge

  2. Post-Traumatic Cognitions Inventory (PTCI)

    The PTCI (Foa et al., 1999) is administered asking participants to report on their experience of post-traumatic cognitions in the previous week.

    Measured: Baseline, Mid-intervention (~1 week post-baseline), Post-intervention (~2 weeks post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-discharge

  3. PTSD Checklist for DSM-5 (PCL-5)

    The PCL-5 (Weathers et al., 2013; German version by Ehring, Knaevelsrud, Krüger \& Schäfer) is administered asking participants to report on their experience of post-traumatic symptoms in the previous week.

    Measured: Baseline, Mid-intervention (~1 week post-baseline), Post-intervention (~2 weeks post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-discharge

  4. Intrusions Questionnaire

    The intrusions questionnaire asks participants to report on the frequency and characteristics of intrusive memories of trauma in the preceding week

    Measured: Baseline, Mid-intervention (~1 week post-baseline), Post-intervention (~2 weeks post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-discharge

  5. Trauma Implicit Associations Test (IAT)

    As developed by Lindgren et al. (2013)

    Measured: Baseline, Post-intervention (~2 weeks post-baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionJan 2019
  4. Study completionMay 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02687555
Sponsor's protocol ID
32-12/14
Other IDs
204, 15-5477
Status last verified
Sep 2019
First submitted
16 Feb 2016
Last updated
17 Sep 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: It is planned to make individual participant data available on publication of the associated study results, via a publically-available data repository such as Open Science Framework. Data made available will be the research data reported in the publication, with the exception of any data that could compromise participant anonymity.

Publications

  • Woud ML, Blackwell SE, Cwik JC, Margraf J, Holmes EA, Steudte-Schmiedgen S, Herpertz S, Kessler H. Augmenting inpatient treatment for post-traumatic stress disorder with a computerised cognitive bias modification procedure targeting appraisals (CBM-App): protocol for a randomised controlled trial. BMJ Open. 2018 Jun 30;8(6):e019964. doi: 10.1136/bmjopen-2017-019964.

    PubMed 29961004

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Cognitive Bias Modification of Appraisals (CBM-App) in people with Post-Traumatic Stress Disorder, run by Ruhr University of Bochum at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dysfunctional trauma-related appraisals as measured using an open-ended ambiguous scenarios task (time frame: Post-intervention (~ 2 weeks post-baseline)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02687555, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in